New Study Shows Potential to Eliminate Osteonecrosis Risk in Osteoporosis and Brain Cancer Patients
Source: Pixabay.com

New Study Shows Potential to Eliminate Osteonecrosis Risk in Osteoporosis and Brain Cancer Patients

Biophosphonates (BPs) are common treatments for osteoporosis and metastatic bone cancer. They help to prevent bone loss. Unfortunately, these drugs can have serious side effects. One of the most severe…

Continue Reading New Study Shows Potential to Eliminate Osteonecrosis Risk in Osteoporosis and Brain Cancer Patients